Day: February 19, 2021

THIS ANNOUNCEMENT, INCLUDING THE APPENDICES AND THE INFORMATION CONTAINED THEREIN, IS RESTRICTED AND IS NOT FOR PUBLICATION, RELEASE, DISTRIBUTION OR FORWARDING, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, AUSTRALIA, JAPAN, THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH SUCH PUBLICATION, RELEASE OR DISTRIBUTION WOULD BE UNLAWFUL.FURTHER, THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND DOES NOT CONSTITUTE AN OFFER OF SECURITIES IN ANY JURISDICTION. PLEASE SEE THE IMPORTANT NOTICES AT THE END OF THIS ANNOUNCEMENT.This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 which is part of UK law by virtue of the European Union (Withdrawal) Act 2018.Terms used in this announcement have the same meaning given to them as defined in the Placing...

Dallas, Feb. 19, 2021 (GLOBE NEWSWIRE) — Thryv Holdings, Inc. (NASDAQ:THRY), the provider of Thryv® software, the end-to-end client experience platform for growing small businesses, today announced that CEO and President Joe Walsh will speak at the Virtual KeyBanc Capital Markets 2021 Emerging Technology Summit at 10:55 a.m. ET on Tuesday, February 23.A live webcast will be available on Thryv’s Investor Relations page at investor.thryv.com. An archived replay will be made available for a limited time at the same location following the event. About Thryv Holdings, Inc.The company owns the easy-to-use Thryv® end-to-end customer experience software built for growing small businesses that helps over 40,000 SaaS clients with the daily demands of running a business. With Thryv, they can get the job, manage the job and get credit. Thryv’s...

SAN FRANCISCO, Feb. 19, 2021 (GLOBE NEWSWIRE) — BridgeBio Pharma, Inc. (Nasdaq: BBIO), a clinical-stage biopharmaceutical company founded to discover, create, test and deliver meaningful medicines for patients with genetic diseases and cancers with clear genetic drivers, and affiliate ML Bio Solutions today announced that the first patient has been dosed in a Phase 2 trial of BBP-418 in patients with LGMD2i. BridgeBio and ML Bio’s BBP-418 is the first-ever oral disease-modifying investigational treatment for LGMD2i. BBP-418 was granted Orphan Drug Designation for LGMD2i by the US Food and Drug Administration (FDA) in 2019, and for LGMD by the European Medicines Agency (EMA) in 2020.LGMD2i is an inherited recessive muscular dystrophy caused by mutation of fukutin-related protein (FKRP). FKRP is an enzyme that adds a sugar molecule to...

Gaithersburg, MD, Feb. 19, 2021 (GLOBE NEWSWIRE) — mPhase Technologies, Inc. (OTC Pink: XDSL) (“mPhase” or the “Company”) is pleased to report that due to its increased cash flow, the Company has accelerated work on several new projects spearheaded by its learning management system (“LMS”) and artificial intelligence (“AI”) teams. These technology projects involve development work for an existing channel partner and a new corporate client. With its improving financial condition, mPhase is also increasing its bidding on additional projects that can leverage its team of experts in AI and data analysis.The Company is adding resources in key areas of need to support these development efforts. In terms of market expansion, mPhase is working on its first project for a Japanese client, as part of a goal to expand its client-base to additional...

KESLA OYJ                                             PÖRSSITIEDOTE             19.2.2021      KLO 14:30Markku Lappalainen Kesla Oyj:n traktorivarusteet -liiketoimintayksikön johtajaksiKeslan uudeksi traktorivarusteiden liiketoimintajohtajaksi ja johtoryhmän jäseneksi on nimitetty insinööri MBA Markku Lappalainen. Markku on tehnyt pitkän uran kansainvälisen myynnin, markkinoinnin ja teollisuuden johtotehtävissä Agcolla ja LLP Farm Machinery Group Oy:n toimitusjohtajana. Keslalle Lappalainen siirtyy Toyota Gazoo Racing World Rally Teamistä ja hän aloittaa uudessa tehtävässään 15.3.2021.KESLA OYJSimo SaastamoinentoimitusjohtajaLISÄTIETOJA:Toimitusjohtaja Simo Saastamoinen, 040 560 9310JAKELU:Nasdaq HelsinkiKeskeiset tiedotusvälineetwww.kesla.comKesla on metsäteknologian ja materiaalikäsittelyn kehittämiseen, markkinointiin ja valmistukseen...

Company Strengthens Balance SheetST. PETERSBURG, FL, Feb. 19, 2021 (GLOBE NEWSWIRE) — Global Technologies, Ltd (OTC Pink: GTLL), a holding corporation, which through its subsidiaries, has operations engaged in the online sales of CBD and hemp related products, the acquisition of intellectual property in the safety and security space and as a portal for entrepreneurs to provide immediate access to live shopping, e-commerce, product placement in brick and mortar retail outlets and logistics is pleased to provide shareholders an overview of its current operations.The Company’s current operations are centered around its two wholly owned subsidiaries, Markets on Main, LLC and HMNRTH, LLC.Markets on Main (“MOM”) provides services to its clients inclusive of: inventory management, brand management, fulfillment and drop-ship capabilities,...

STOCKHOLM, SVERIGE – February 19, 2021. Karolinska Development AB (publ) (“Karolinska Development” or the “Company”) held an Extraordinary General Meeting on February 19, 2021. Due to the continued spread of the coronavirus and the authorities’ regulations/advice on avoiding public gatherings, the Extraordinary General Meeting was conducted only through postal voting and thus without physical presence of shareholders, proxies or external parties. The following resolutions were passed by the shareholders at the Extraordinary General Meeting:Election of Chairman of the Board of Directors and directors: it was resolved, in accordance with the Nomination Committee’s proposal, to elect Anna Lefevre Skjöldebrand and Ben Toogood as new directors, and to elect Björn Cochlovius as new chairman of the Board of Directors.The Board of Directors’...

STOCKHOLM, SVERIGE – 19 februari 2021. Karolinska Development AB (publ) (”Karolinska Development” eller ”Bolaget”) höll den 19 februari 2021 extra bolagsstämma. Med anledning av den fortsatta spridningen av coronaviruset och myndigheternas föreskrifter/råd om undvikande av sammankomster genomfördes den extra bolagsstämman endast genom poströstning och således utan fysisk närvaro av aktieägare, ombud eller utomstående. Vid den extra bolagsstämman beslutade aktieägarna följande:Val av styrelsens ordförande och styrelseledamöter: beslöts i enlighet med valberedningens förslag att välja Anna Lefevre Skjöldebrand och Ben Toogood till nya styrelseledamöter; att välja Björn Cochlovius till ny styrelseordförande.Styrelsens förslag till beslut om riktlinjer för ersättning till ledande befattningshavare: beslöts att godkänna styrelsens förslag...